Westgate Surgery’s Role in Groundbreaking Cervical Screening Research



OneMedicare | HPValidate Study Participation

Study Results Boost Case for Self-Sampling in the NHS

In a major advancement for cervical screening, the HPValidate study, launched in 2021, has released its final results, offering compelling evidence for the introduction of self-sampling as a viable alternative to traditional clinician-led tests. The study explored whether self-collected vaginal samples could match the accuracy of clinician-taken samples in detecting Human Papillomavirus (HPV), the leading cause of cervical cancer.

Westgate Surgery’s Involvement

Westgate GP Practice, operated by OneMedicare, proudly took part in the HPValidate study, contributing to a national effort to improve and diversify cervical screening methods. Through this initiative, Westgate played a key role in gathering crucial data that may shape the future of the NHS Cervical Screening Programme, particularly by helping to reach individuals who are less likely to attend in-person appointments.

How the Study Worked

The HPValidate study involved over 6,000 participants from GP practices and colposcopy clinics across the UK. Participants used a range of self-sampling devices to collect their own samples, which were then tested in laboratories alongside traditional clinician-collected samples.

Key findings included:

  • Accuracy of Self-Sampling Devices
    Four self-collection device and test combinations were found to be as accurate as clinician-taken samples for detecting HPV:

    • Evalyn Brush + Cobas

    • FLOQswabs + Cobas

    • FLOQswabs + Aptima

    • Aptima Multitest + Aptima

  • Patient Experience

    • 75% rated their experience as excellent

    • 23% rated it as good

    • Only 1% experienced significant discomfort

  • Preference for Choice

    • 85% of participants said they would like the option of self-sampling

    • 23% found it hard to choose between self-sampling and clinician-led screening

    • 48% said they’d prefer a recommendation from a healthcare provider

Looking Ahead: A Shift Towards Patient-Centered Screening

The findings reinforce the idea that self-sampling could be a game-changer for cervical screening in the NHS. Not only is it clinically reliable, but it also empowers patients by offering greater choice, particularly for those who feel uncomfortable with or are unable to attend clinician appointments.

Westgate Surgery is proud to have supported research that promotes accessibility, comfort, and inclusivity in preventive healthcare. As evidence continues to grow, it is likely that self-sampling will become a key tool in increasing screening uptake and preventing cervical cancer.